Breath markers for therapeutic radiation

Authors:

Abstract
We read with much interest the letter by Tuscano et al. [ [1] Tuscano C, Sceni G, Sayyad S Al. Letter to the Editor of Radiotherapy and Oncology regarding the paper entitled “50 years of radiotherapy research: Evolution, trends and lessons for the future“ by Berger et al. Radiother Oncol 2022. Google Scholar ] relating to our analysis of 50 years of PubMed records on Radiotherapy [ [2] Berger T. Noble D.J. Shelley L.E.A. Hopkins K.I. McLaren D.B. Burnet N.G. et al. 50 years of radiotherapy research: Evolution, trends and lessons for the future. Radiother Oncol. 2021; 165 : 75-86 https://doi.org/10.1016/J.RADONC.2021.09.026/ATTACHMENT/C3D14F73-7E99-4A4C-92AF-1DE741CBFA2F/MMC3.TXT Google Scholar ] and thank them for sharing their reflections on how to rebalance and further develop our discipline in the future. We share their views on the importance of the role to be played by biology to achieve improved personalisation of Radiotherapy treatments, which they neatly encapsulated in the term dose painting by bio-features. More specifically, we strongly believe that incorporating patient-specific biological information such as, tumour and normal tissue radio-sensitivity [ 3 Salman D. Eddleston M. Darnley K. Nailon W.H. McLaren D.B. Hadjithelki A. et al. Breath markers for therapeutic radiation. J Breath Res. 2020; 15 https://doi.org/10.1088/1752-7163/ABA816 Google Scholar , 4 Meehan J. Gray M. Martínez-Pérez C. Kay C. Pang L.Y. Fraser J.A. et al. Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer. Front Oncol. 2020; 10 : 628 https://doi.org/10.3389/FONC.2020.00628/BIBTEX Google Scholar , 5 Kerns S.L. Fachal L. Dorling L. Barnett G.C. Baran A. Peterson D.R. et al. Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy. JNCI J Natl Cancer Inst. 2020; 112 : 179-190 Google Scholar ] either evaluated pre-treatment via radio-genomics for instance, or in vivo via imaging and radiomic analysis [ 6 Cheng K. Montgomery D. Feng Y. Steel R. Liao H. McLaren D.B. et al. Identifying radiotherapy target volumes in brain cancer by image analysis. Healthc Technol Lett. 2015; 2 : 123-128 Google Scholar , 7 Feng Y. Welsh D. McDonald K. Carruthers L. Cheng K. Montgomery D. et al. Identifying the dominant prostate cancer focal lesion using image analysis and planning of a simultaneous integrated stereotactic boost. Http://DxDoiOrg/103109/0284186X20151063782. 2015; 54 : 1543-1550 Google Scholar ], is a promising strategy which will ultimately translate into clinical benefits for patients [ [8] Scaife J.E. Barnett G.C. Noble D.J. Jena R. Thomas S.J. West C.M.L. et al. Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment. Br J Radiol. 2015; 88 : 20150172 Google Scholar ].
Funding Information
  • H2020 (TOXI-triage: grant agreement No. 65)

This publication has 34 references indexed in Scilit: